Tianyu Pharmaceutical's API passes technical review of CDE

On 6 Jan., 2022, Zhejiang Tianyu Pharmaceutical Co., Ltd. (Tianyu Pharmaceutical) announced that its active pharmaceutical ingredient (API) of Proline Heng'ge Liejing passed technical review of Center for Drug Evaluation (CDE) of the National Medical...

Amino Acids China E-News 202201

www.cnchemicals.com